5,6-Dihydro-3-(4-morpholinyl)-1-(4-nitrophenyl)-2(1H)-pyridinone

Suzhou Nordica Biopharma Co., Ltd is a technology-driven and innovative company dedicated to the R&D, production, and sales of bio-pharmaceuticals and new materials. Our main products covers multiple fields such as diabetes, oncology, neurological diseases, cardiovascular diseases, and anti-infectives. We have modern production facility and R&D center, and our head office is located in Suzhou. Our company has a highly skilled R&D team and collaborates with renowned research institutes and universities. We are committed to the R&D of generic drugs, continuously launching products with independent intellectual property rights and competitiveness. With over 10 years of industry experience, our senior team provides professional and high-quality services to domestic and international customers. To ensure the quality of products and timely delivery, our company has established a strictly quality control system. Suzhou Nordica Biopharma Co., Ltd is a technology-driven company with strategy of “creating value and win-win”, we are continuously improving product quality and technical level, striving to become a leading technology-driven innovative company. We are willing to cooperate with friends from all sectors to contribute to the development of China’s bio-pharmaceutical industry.